Given the pivotal role of FTO in CAF-mediated angiogenesis and the critical role of angiogenesis in tumor progression and spread, the authors proposed FTO as a promising antiangiogenic therapeutic target to improve CM treatment. This evidence concerns the gene FTO and neoplasm.